STRO vs VZ · rev $62.0M vs P/E 11, rev $138.19B
Sutro Biopharma (STRO) versus Verizon Communications Inc (VZ) — a side-by-side from cached financials, not a winner call.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Verizon Communications Inc (VZ) is a telecom services company listed on NYSE. It is led by Hans Vestberg.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
Latest reported VZ revenue for 2025-12-31 was $138.19B. Net income was $17.17B. Revenue was up 2.5% from 2024-12-31 to 2025-12-31. VZ currently screens at market cap $191.41B and trailing P/E 11.2.
STRO currently screens at market cap $470.8M. VZ currently screens at market cap $191.41B and trailing P/E 11.2.
Not investment advice. Open the STRO and VZ stock pages for the full models.
Not investment advice.